Redemplo (plozasiran)

Approved for REDEMPLO is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).. Plozasiran is a siRNA conjugated with GalNAc that degrades apoC-III mRNA through RNA interference, reducing triglycerides. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC pricing.

Loading full data from Know Your Drugs Institute…